AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home Mycology Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Article | Open Access

Modulation of Bax and Bcl-2 genes by secondary metabolites produced by Penicillium rubens JGIPR9 causes the apoptosis of cancer cell lines

Prerana Venkatachalam,Varalakshmi Kilingar Nadumane ( )
Department of Biotechnology, School of Sciences, JAIN (Deemed-to-be University), Bengaluru, India
Show Author Information

Abstract

Search for an efficient anti-cancer compound of natural origin with well-defined mechanisms of action is an important scientific pursuit today, due to cancer being the second leading cause for the death of affected people. The members of the genus Penicillium are one of the important sources of bioactive compounds. In the present study, Penicillium rubens, isolated from a garden soil in Madurai district of Tamil Nadu, was found to produce a highly promising anti-cancer metabolite. The percentage viabilities of HepG2, HeLa and MCF-7 cancer cells treated with the bioactive fraction (P5) isolated from P. rubens, ranged between 40-50% after 96 h. Apoptosis induction was found to be the major reason for the observed reduction in cancer cell proliferation and cell count which was confirmed by caspase activity, DNA fragmentation, clonogenic assay, cell cycle analysis and LDH assays. The upregulation of proapoptotic Bax, coupled with the downregulation of anti-apoptotic Bcl-2 expressions were confirmed by RT-qPCR and flow cytometry methods. The current study also indicated an upregulation of p53 which further strengthened the apoptogenic property of P5 fraction. Non-toxicity of P5 was demonstrated on normal peripheral lymphocytes. The analysis of P5 fraction through GC-MS indicated the presence of indole-2, 3-(4,4-dimethyl-3-thiosemicarbazone) as one of the major compounds.

References

 
Aneja KR. 2003. Experiments in microbiology, plant pathology and biotechnology. In: Cultivation techniques for isolation and enumeration of microorganisms. 4th ed. New Delhi: New Age International Publishers; p. 154–188.
 

Basu A, Haldar S. 1998. The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod. 4:1099–1109.

 

Béchohra L, Laraba-Djebari F, Hammoudi-Triki D. 2016. Cytotoxic activity of Androctonusaustralis hector venom and its toxic fractions on human lung cancer cell line. J Venom Anim Toxins Incl Trop Dis. 22:29.

 

Belayachi L, Aceves-Luquero C, Merghoub N, de Mattos SF, Amzazi S, Villalonga P, Bakri Y. 2017. Induction of cell cycle arrest and apoptosis by Ormeniseriolepis a Morrocan endemic plant in various human cancer cell lines. Afr J Tradit Complement Altern Med. 14(2):356–373.

 

Bhatnagar I, Kim SK. 2010. Marine antitumour drugs: status, shortfalls and strategies. Mar Drugs. 8:2702–2720.

 

Bladt TT, Frisvad JC, Knudsen PB, Larsen TO. 2013. Anticancer and antifungal compounds from Aspergillus, Penicillium and other filamentous fungi. Molecules. 18:11338–11376.

 
Brousseau P, Payette Y, Tryphonas H, Blakley B, Flipo D, Fournier M. 1999. Assessment of cell viability: determination of cell viability and cell concentration with ethidium bromide and acridine orange. In: Beudet M, Kouassi E, Lapierre P, Voccia I, Raton FLB, editors. Manual of immunological methods. Boca Raton (FL): CRC Press LLC; p. 28–29.
 

Burgess A, Wigan M, Giles N, DePinto W, Gillespie P, Stevens F, Gabrielli B. 2006. Inhibition of S/G2 phase CDK4 reduces mitotic fidelity. J Biol Chem. 281(15):9987–9995.

 

Calvo AM, Wilson RA, Bok JW, Keller NP. 2002. Relationship between secondary metabolism and fungal development. Microbiol Mol Biol Rev. 66:447–459.

 

Chavez R, Fierro F, Garcia-Rico RO, Vaca I. 2015. Filamentous fungi from extreme environments as a promising source of novel bioactive secondary metabolites. Front Microbiol. 6:903.

 

da Rocha AB, Lopes RM, Schwartsmann G. 2001. Natural products in anticancer therapy. Curr Opin Pharmacol. 1:364–369.

 

da Silva TC, Cogliati B, Latorre AO, Akisue G, Nagamine MK, Haraguchi M, Hansen D, Sanches DS, Dagli MLZ. 2015. Pfaffosidic fraction from Hebanthepaniculatainduces cell cycle arrest and caspase-3-induced apoptosis in HepG2 cells. Evid Based Complement Alternat Med. 2015:1–9. Article ID:835796.

 
De Hoog GS, Guarro J, Gene J, Figueras F. 2000. Atlas of clinical fungi. 2nd ed. Utrecht (The Netherlands): Central Bureau voorSchimmelcultures.
 

de Sousa AR, Penalva LO, Marcotte EM, Vogel C. 2009. Global signatures of protein and mRNA expression levels. Mol Biosyst. 5:1512–1526.

 

Demain AL, Sanchez S. 2009. Microbial drug discovery: 80 years of progress. J Antibiot. 62:5–16.

 

Ding AH, Nathan CF, Stuehr DJ. 1998. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 141:2407–2412.

 

F K-M C, Moriwaki K, De Rosa MJ. 2013. Detection of necrosis by release of lactate dehydrogenase (LDH) activity. Methods Mol Biol. 979:65–70.

 

Farha AK, Hatha AM. 2019. Bioprospecting potential and secondary metabolite profile of a novel sediment-derived fungus Penicillium sp. ArCSPf from continental slope of Eastern Arabian Sea. Mycology. 10(2):109–117.

 

Feng Q, Yu Y, Tang M, Zhang T, Zhang M, Wang H, Han Y, Zhang Y, Chen G, Pei Y. 2018. Four new hybrid polyketide-terpenoid metabolites from the Penicillium sp. SYPF7381 in the rhizosphere soil of Pulsatillachinensis. Fitoterapia. 125:249–257.

 

Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nat Protoc. 1:2315–2319.

 
Freshney IR. 2000. Culture of animal cells - A manual of basic techniques. 4th ed. New York: A. John Wiley & sons, Inc
 

Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:493–501.

 

Gomes NGM, Lefranc F, Kijjoa A, Kiss R. 2015. Can some marine-derived fungal metabolites become actual anticancer agents? Mar Drugs. 13:3950–3991.

 

Hall MD, Salam NK, Hellawell JL, Fales HM, Kensler CB, Ludwig JA, Szakacs G, Hibbs DE, Gottesman MM. 2009. Synthesis, activity and pharmacophore development for isatin-β-thiosemicarbazones with selective activity towards multidrug resistant cells. J Med Chem. 52(10):3191–3204.

 

Hsieh TC, Juan G, Darzynkiewicz Z, Wu JM. 1999. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21WAF1/CIP1, and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59:2596–2601.

 

Hussein MA, Iqbal MA, Umar MI, Haque RA, Guan TS. 2015. Synthesis, structural elucidation and cytotoxicity of new thiosemicarbazone derivatives. Arab J Chem. doi:10.1016/j.arabjc.2015.08.013.

 

Ibrahim SA, Elsaman T. 2018. Cytotoxic and anticancer activities of indoline-2,3-dione (Isatin) and its derivatives. Int J Pharm Res. 21:1–19.

 

Kajstura M, Halicka HD, Pryjma J, Darzynkiewicz Z. 2007. Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete “Sub-G1” peaks on DNA content histograms. Cytometry A. 71(3):125–131.

 

Kinghorn D, EJC DB, Lucas DM, Rakotondraibe HL, Orjala J, Soejarto DD, Oberlies NH, Pearce CJ, Wani MC, Stockwell BR, et al. 2016. Discovery of anticancer agents of diverse natural origin. Anticancer Res. 36:5623–5638.

 

Kornienko A, Evidente A, Vurro M, Mathieu V, Cimmino A, Evidente M, van Otterlo WA, Dasari R, Lefranc F, Kiss R. 2015. Towards a cancer drug of fungal origin. Med Res Rev. 35:937–967.

 

Koul M, Singh S. 2017. Penicillium spp.: prolific producer for harnessing cytotoxic secondary metabolites. Anticancer Drugs. 28:11–30.

 

Liu Y, Beyer A, Aebersold R. 2016. On the dependency of cellular protein levels on mRNA abundance. Cell. 165:535–550.

 

Maier T, Güell M, Serrano L. 2009. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 583:3966–3973.

 

Martin JHJ, Alalami O, van den Berg HW. 1999. Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence. Cancer Lett. 144:65–74.

 

Mathi P, Nikhil K, Ambatipudi N, Roy P, Bokka VR, Botlagunta M. 2014. In-vitro and in-silico characterization of Sophora interrupta plant extract as an anticancer activity. Bioinformation. 10:144–151.

 
Mathur R. 2017. National ethical guidelines for biomedical and health research involving human participants. New Delhi: ICMR.
 

Mohammad S, Mhaindarkar VP, Kumar S, Khan MI, Bhosale SH. 2011. Isolation and phylogenetic analysis of marine fungus Penicillium sp. sdbf1 and partial characterization of its cysteine protease inhibitor. Int J Adv Biotechnol Res. 2:135–142.

 

Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immuno Methods. 65:55–63.

 

Nicoletti R, Trincone A. 2016. Bioactive compounds produced by strains of Penicillium and Talaromyces of marine origin. Mar Drugs. 14:37.

 
Orfali R, Perveen S. 2019. New bioactive metabolites from the Thermophilic fungus Penicillium sp. isolated from Ghamiqa hot spring in Saudi Arabia. J Chem. 2019:1–7. Article ID 7162948.
 

Paul S, Mandal SK, Bhattacharyya SS, Boujedaini N, Khuda-Bukhsh AR. 2010. In vitro and in vivo studies demonstrate anticancer property of root extract of Polygala senega. J Acupunct Meridian Stud. 3:188–196.

 

Pittayakhajonwut P, Dramae A, Intaraudom C, Boonyuen N, Nithithanasilp S, Rachtawee P, Laksanacharoen P. 2011. Two new drimane sesquiterpenes, fudecadiones A and B, from the soil fungus Penicillium sp. BCC 17468. Planta Med. 77:74–76.

 

Rabel F, Sherma J. 2017. Review of the state of the art of preparative thin-layer chromatography. J Liq Chromatogr Relat Technol. 40(4):165–176.

 

Venkatachalam, Nadumane. 2018. Overexpression of p53 and Bax mediating apoptosis in cancer cell lines induced by a bioactive compound from Bacillus endophyticus JUPR15. Process Biochem. 73:170–179.

 

Youssef DTA, Alahdal AM. 2018. Cytotoxic and antimicrobial compounds from the marine-derived fungus, Penicillium species. Molecules. 23:E394.

Mycology
Pages 69-81
Cite this article:
Venkatachalam P, Nadumane VK. Modulation of Bax and Bcl-2 genes by secondary metabolites produced by Penicillium rubens JGIPR9 causes the apoptosis of cancer cell lines. Mycology, 2021, 12(2): 69-81. https://doi.org/10.1080/21501203.2019.1707315

232

Views

9

Crossref

8

Web of Science

10

Scopus

Altmetrics

Received: 29 September 2019
Accepted: 03 December 2019
Published: 26 December 2019
© 2019 The Author(s).

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Return